Fishers, IN, United States of America

Joseph Chabenne



 

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 113(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Joseph Chabenne: Innovator in Glucagon Peptide Research

Introduction

Joseph Chabenne is a notable inventor based in Fishers, IN (US). He has made significant contributions to the field of biochemistry, particularly in the development of glucagon peptides. With a total of 6 patents to his name, Chabenne's work has the potential to impact therapeutic approaches for metabolic disorders.

Latest Patents

Chabenne's latest patents focus on glucagon/GLP-1 receptor co-agonists. These modified glucagon peptides exhibit enhanced potency at the glucagon receptor compared to native glucagon. Further modifications, such as forming lactam bridges or substituting the terminal carboxylic acid with an amide group, result in peptides that demonstrate glucagon/GLP-1 receptor co-agonist activity. The solubility and stability of these high-potency glucagon analogs can be improved through pegylation, substitution of carboxy terminal amino acids, or the addition of specific carboxy terminal peptides.

Career Highlights

Throughout his career, Joseph Chabenne has worked with esteemed institutions, including Indiana University and MSD Italia S.r.l. His research has contributed to advancements in peptide technology and therapeutic applications.

Collaborations

Chabenne has collaborated with notable colleagues, including Richard Dennis DiMarchi and Maria DiMarchi. These partnerships have fostered innovation and development in the field of glucagon peptides.

Conclusion

Joseph Chabenne's work in glucagon peptide research exemplifies the impact of innovative thinking in biochemistry. His contributions continue to pave the way for advancements in metabolic disorder treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…